ResMed Named Top-20 Corporate Citizen by Forbes, JUST
ResMed #1 among healthcare equipment and services companies

SAN DIEGO – December 10, 2018 – ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today was named one of America’s top 100 corporate citizens for the third straight year by Forbes and JUST Capital, a nonprofit that analyzes and ranks companies based on how they serve the priorities of the American people.

ResMed ranked #18 out of 890 large publicly traded U.S. companies – and #1 out of 32 “Health Care Equipment & Services” companies – when compared on issues including:

  • Worker compensation and wellbeing
  • Customer treatment
  • Product impact
  • Environmental impact
  • Community support
  • Job creation

“Improving lives is ResMed’s mission, and that has to start within your own company,” said ResMed CEO Mick Farrell. “At ResMed, we provide a diverse, inclusive and dynamic work environment that fosters the growth and innovation of more than 6,000 ResMedians worldwide. It’s our team of dedicated professionals that makes ResMed global leaders in connected medical devices and out-of-hospital software, improving millions of lives and changing the way healthcare companies do business.”

“We’re proud to help raise the bar for corporate responsibility, and will continue to do so,” Farrell said.

See every 2019 JUST 100 company here.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

###

MEDIA: Jayme Rubenstein, 858.836.6798, news@resmed.com | INVESTORS: Amy Wakeham, 858.836.5000, investorrelations@resmed.com
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages